Finance

Lists
PHN:BIT
Pharmanutra SpA
€72,50
+1,54%
(+1,10) 1D
6 Okt., 17:35:14 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHN...
Open
€71,90
High
€73,10
Low
€71,70
Mkt. cap
689,50 m
Avg. vol.
18,71 k
Volume
17,03 k
Dividend
1,66%
Quarterly dividend
€0,30
Ex-dividend date
04 Mei 2026
P/E ratio
33,47
52-wk high
€95,90
52-wk low
€43,55
EPS
€2,17
Shares outstanding
9,68 m
No. of employees
144
Open
€71,90
High
€73,10
Low
€71,70
Mkt. cap
689,50 m
Avg. vol.
18,71 k
Volume
17,03 k
Dividend
1,66%
Quarterly dividend
€0,30
Ex-dividend date
04 Mei 2026
P/E ratio
33,47
52-wk high
€95,90
52-wk low
€43,55
EPS
€2,17
Shares outstanding
9,68 m
No. of employees
144
News stories
From web sources and news partners
About Pharmanutra SpA
CEO-
Employees144
Founded2000
Headquarters-
SectorPersonal care products
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
31,86 m
37,20 m
33,24 m
40,50 m
Cost of goods sold
34,06 m
19,19 m
17,23 m
19,42 m
Cost of revenue
34,06 m
19,19 m
17,23 m
19,42 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-10,08 m
9,22 m
9,56 m
9,80 m
Operating expense
-9,26 m
10,39 m
10,82 m
11,11 m
Total operating expenses
24,80 m
29,58 m
28,05 m
30,53 m
Operating income
7,06 m
7,62 m
5,19 m
9,98 m
Other non operating income
707,00 k
937,00 k
89,00 k
9,00 k
EBT including unusual items
7,60 m
8,17 m
5,26 m
9,94 m
EBT excluding unusual items
7,60 m
8,50 m
5,26 m
9,94 m
Income tax expense
2,81 m
2,19 m
1,82 m
3,49 m
Effective tax rate
37,00%
26,83%
34,53%
35,07%
Other operating expenses
143,00 k
303,00 k
314,00 k
64,00 k
Net income
4,82 m
5,99 m
3,46 m
6,47 m
Net profit margin
15,14%
16,11%
10,40%
15,98%
Earnings per share
-
-
-
-
Interest and investment income
95,00 k
134,00 k
156,00 k
130,00 k
Interest expense
-222,00 k
-143,00 k
-137,00 k
-132,00 k
Net interest expenses
-127,00 k
-9,00 k
19,00 k
-2,00 k
Depreciation and amortization charges
671,00 k
864,00 k
947,00 k
1,25 m
EBITDA
7,53 m
7,83 m
6,01 m
11,03 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme